We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sharfstein: FDA Should Allow Mass Compounding, Drug Imports
Sharfstein: FDA Should Allow Mass Compounding, Drug Imports
A journal article asking the FDA to defy its own policies concerning mass compounding and drug importation to combat rising drug prices comes from an unusual source: the agency’s former second-in-command.